ECSP093680A - Proceso para derivados del acido fenilacetico - Google Patents

Proceso para derivados del acido fenilacetico

Info

Publication number
ECSP093680A
ECSP093680A EC2009003680A ECSP093680A ECSP093680A EC SP093680 A ECSP093680 A EC SP093680A EC 2009003680 A EC2009003680 A EC 2009003680A EC SP093680 A ECSP093680 A EC SP093680A EC SP093680 A ECSP093680 A EC SP093680A
Authority
EC
Ecuador
Prior art keywords
formula
acid derivatives
phenylacetic acid
precursors
pharmaceutically acceptable
Prior art date
Application number
EC2009003680A
Other languages
English (en)
Inventor
Murat Acemoglu
Olivier Loiseleur
Gottfried Sedelmeier
Thomas Allmendinger
John Vincent Calienni
Jacques Cercus
David Xu
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of ECSP093680A publication Critical patent/ECSP093680A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/43—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C07C211/44—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to only one six-membered aromatic ring
    • C07C211/52—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to only one six-membered aromatic ring the carbon skeleton being further substituted by halogen atoms or by nitro or nitroso groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/43—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C07C211/54—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to two or three six-membered aromatic rings
    • C07C211/56—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to two or three six-membered aromatic rings the carbon skeleton being further substituted by halogen atoms or by nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/22—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from lactams, cyclic ketones or cyclic oximes, e.g. by reactions involving Beckmann rearrangement
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/40—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/42—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton with carboxyl groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by saturated carbon chains
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/12—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by halogen atoms or by nitro or nitroso groups
    • C07C233/15—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by halogen atoms or by nitro or nitroso groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C235/16—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C235/18—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides
    • C07C235/24—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/34—Oxygen atoms in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Abstract

Un proceso para la producción de un compuesto de la Fórmula I, o una sal farmacéuticamente aceptable del mismo, o un éster de profármaco farmacéuticamente aceptable del mismo; el cual comprende hidrolizar una lactama de la fórmula II; en donde los símbolos son como se definen, con una base; y precursores del mismo, y procesos para la preparación de los precursores. Los compuestos de la Fórmula I son compuestos farmacéuticamente activos que son inhibidores selectivos de la Ciclo-oxigenasa II.
EC2009003680A 1999-09-27 2009-01-13 Proceso para derivados del acido fenilacetico ECSP093680A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9922830.6A GB9922830D0 (en) 1999-09-27 1999-09-27 Processes

Publications (1)

Publication Number Publication Date
ECSP093680A true ECSP093680A (es) 2009-02-27

Family

ID=10861676

Family Applications (2)

Application Number Title Priority Date Filing Date
EC2000003680A ECSP003680A (es) 1999-09-27 2000-09-25 Proceso para derivados del acido fenilacetico
EC2009003680A ECSP093680A (es) 1999-09-27 2009-01-13 Proceso para derivados del acido fenilacetico

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EC2000003680A ECSP003680A (es) 1999-09-27 2000-09-25 Proceso para derivados del acido fenilacetico

Country Status (34)

Country Link
US (2) US20080249318A1 (es)
EP (2) EP1216226B1 (es)
JP (1) JP2003510303A (es)
KR (1) KR100745341B1 (es)
CN (1) CN100412053C (es)
AR (2) AR031529A1 (es)
AT (1) ATE447547T1 (es)
AU (1) AU775416B2 (es)
BR (1) BR0014314A (es)
CA (1) CA2379553C (es)
CO (1) CO5210865A1 (es)
CY (1) CY1110539T1 (es)
CZ (1) CZ20021027A3 (es)
DE (1) DE60043261D1 (es)
DK (1) DK1216226T3 (es)
EC (2) ECSP003680A (es)
ES (1) ES2338209T3 (es)
GB (1) GB9922830D0 (es)
HK (1) HK1047739A1 (es)
HU (1) HUP0202728A3 (es)
IL (2) IL148330A0 (es)
MY (1) MY125201A (es)
NO (1) NO327912B1 (es)
NZ (1) NZ517461A (es)
PE (1) PE20010644A1 (es)
PL (1) PL207777B1 (es)
PT (1) PT1216226E (es)
RU (1) RU2273628C2 (es)
SI (1) SI1216226T1 (es)
SK (1) SK287241B6 (es)
TR (1) TR200200745T2 (es)
TW (1) TWI270540B (es)
WO (1) WO2001023346A2 (es)
ZA (1) ZA200202367B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0209257D0 (en) * 2002-04-23 2002-06-05 Novartis Ag Organic compounds
US7220749B2 (en) 2002-06-11 2007-05-22 Nitromed, Inc. Nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use
GB0224198D0 (en) * 2002-10-17 2002-11-27 Novartis Ag Organic compounds
PE20040844A1 (es) 2002-11-26 2004-12-30 Novartis Ag Acidos fenilaceticos y derivados como inhibidores de la cox-2
US7161026B1 (en) 2005-07-08 2007-01-09 Property Development Corporation International, Ltd, Inc. Method of preparation of methyl-benzyl-ketone
AR061623A1 (es) 2006-06-26 2008-09-10 Novartis Ag Derivados de acido fenilacetico
US8227451B2 (en) 2008-11-12 2012-07-24 Auspex Pharmaceuticals Phenylacetic acid inhibitors of cyclooxygenase
CN102311355B (zh) * 2011-09-26 2014-02-05 扬州天和药业有限公司 罗本考昔的一种制备方法
CN107721901A (zh) * 2017-11-12 2018-02-23 刘磊 一种2‑[2‑(2,3,5,6‑四氟苯胺基)苯基]乙酸的制备方法
EP3830072A1 (en) 2018-07-27 2021-06-09 KRKA, d.d., Novo mesto A process for the preparation of polymorphic form of robenacoxib
CN116621715A (zh) * 2018-08-03 2023-08-22 日产化学株式会社 氟化芳族仲胺化合物的制造方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3558690A (en) * 1965-04-08 1971-01-26 Gelgy Chemical Corp Substituted derivatives of 2-anilinophenylacetic acids and a process of preparation
IT1097265B (it) 1978-06-23 1985-08-31 Acraf Nouva sintesi di un acido fenilacetico
JPS5677246A (en) * 1980-11-27 1981-06-25 Nissan Chem Ind Ltd Production of substituted phenylacetic acid
DE3404401C2 (de) 1984-02-08 1994-02-10 Hoechst Ag Verwendung von Aryloxy-Verbindungen als Antidots
FR2578836B1 (fr) 1985-03-12 1987-04-17 Rhone Poulenc Spec Chim Procede de chloration selective de composes phenoliques
EP0380712B1 (de) 1989-01-27 1995-01-04 HEUMANN PHARMA GMBH & CO Verfahren zur Herstellung von 2,6-Dichlordiphenylaminessigsäurederivaten
IT1248032B (it) * 1991-06-11 1995-01-05 Laboratorio Chimico Int Spa Procedimento per la preparazione della n- (2,6-diclorofenil) -n-fenil-n-(cloroacetil)-ammina.
CN1091420A (zh) * 1993-02-25 1994-08-31 永信药品工业股份有限公司 二苯胺衍生物的制备方法
JPH0789951A (ja) 1993-06-03 1995-04-04 Sterling Winthrop Inc インターロイキン−１β転換酵素阻害剤
US5475139A (en) 1993-10-22 1995-12-12 Yung Shin Pharm. Ind. Co., Ltd. Method for the preparation of substituted derivatives of diphenyl amine
MX9605196A (es) 1994-04-29 1997-12-31 Sanofi Winthrop Inc Halometilamidas como inhibidores de la proteasa il-1b.
US5576460A (en) 1994-07-27 1996-11-19 Massachusetts Institute Of Technology Preparation of arylamines
JPH0977664A (ja) * 1995-09-13 1997-03-25 Yakult Honsha Co Ltd シクロオキシゲナーゼ−２特異的阻害剤及び抗炎症剤
US6355680B1 (en) 1996-02-20 2002-03-12 Exocell, Inc. Albumin-binding compounds that prevent nonenzymatic glycation and that may be used for treatment of glycation-related pathologies
US6034266A (en) 1996-03-11 2000-03-07 Fundacao Oswaldo Cruz-Fiocruz Gem-difluoro derivative of phenylacetamide and phenylacetic acid and their pharmaceutical uses
BR9600975A (pt) * 1996-03-11 1997-12-30 Fundacao Oswaldo Cruz Derivados do ácido gem-difluorfenilacético e de gem-difluorfenilacetamida processo de sua preparação e suas aplicações farmacêuticas
CA2208900C (en) 1996-07-18 2006-08-01 Lonza Ag Process for preparing 2-pyrimidinecarboxylates
US5817877A (en) 1996-09-23 1998-10-06 Yale University Metal-catalyzed amination of organic sulfonates to organic amines
CO4960662A1 (es) 1997-08-28 2000-09-25 Novartis Ag Ciertos acidos 5-alquil-2-arilaminofenilaceticos y sus derivados

Also Published As

Publication number Publication date
CN1377337A (zh) 2002-10-30
PL207777B1 (pl) 2011-01-31
EP1216226A2 (en) 2002-06-26
TR200200745T2 (tr) 2002-06-21
JP2003510303A (ja) 2003-03-18
WO2001023346A2 (en) 2001-04-05
CA2379553A1 (en) 2001-04-05
CA2379553C (en) 2010-09-21
SK287241B6 (sk) 2010-04-07
PT1216226E (pt) 2009-12-17
MY125201A (en) 2006-07-31
ATE447547T1 (de) 2009-11-15
NO20021368D0 (no) 2002-03-19
AU775416B2 (en) 2004-07-29
EP2275403A1 (en) 2011-01-19
DK1216226T3 (da) 2010-02-01
DE60043261D1 (de) 2009-12-17
US20080249318A1 (en) 2008-10-09
HUP0202728A2 (hu) 2002-12-28
ZA200202367B (en) 2003-02-26
NO327912B1 (no) 2009-10-19
PL365994A1 (en) 2005-01-24
HUP0202728A3 (en) 2003-11-28
US20090275758A1 (en) 2009-11-05
IL148330A (en) 2007-02-11
US7906677B2 (en) 2011-03-15
PE20010644A1 (es) 2001-06-15
CO5210865A1 (es) 2002-10-30
SK4142002A3 (en) 2002-08-06
CZ20021027A3 (cs) 2002-07-17
HK1047739A1 (en) 2003-03-07
SI1216226T1 (sl) 2010-03-31
AU7906700A (en) 2001-04-30
ECSP003680A (es) 2002-04-23
CY1110539T1 (el) 2015-04-29
CN100412053C (zh) 2008-08-20
ES2338209T3 (es) 2010-05-05
EP1216226B1 (en) 2009-11-04
NO20021368L (no) 2002-05-27
AR042404A2 (es) 2005-06-22
GB9922830D0 (en) 1999-11-24
NZ517461A (en) 2003-10-31
IL148330A0 (en) 2002-09-12
BR0014314A (pt) 2002-11-12
RU2273628C2 (ru) 2006-04-10
TWI270540B (en) 2007-01-11
KR100745341B1 (ko) 2007-08-02
KR20020030289A (ko) 2002-04-24
WO2001023346A3 (en) 2002-01-10
AR031529A1 (es) 2003-09-24

Similar Documents

Publication Publication Date Title
ECSP093680A (es) Proceso para derivados del acido fenilacetico
RS50140B (sr) Postupak za dobijanje perkihinina i njegova upotreba
CA2478374A1 (en) N3 alkylated benzimidazole derivatives as mek inhibitors
CU23006A3 (es) Nuevos ésteres derivados de compuestos fenil-ciclonuevos ésteres derivados de compuestos fenil-ciclohexil sustituidos hexil sustituidos
AR029216A1 (es) Compuestos inhibidores no peptidicos de la union celular dependiente de vla-4 utiles en el tratamiento de enfermedades inflamatorias, autoinmunes y respiratorias; composicion farmaceutica y procedimiento de tratamiento
UY27169A1 (es) Derivados del ácido isoftálico como inhibidores de metalproteinasas de la matriz
EA200400981A1 (ru) Новые гетероциклические соединения, активные в качестве ингибиторов бета-лактамаз
ECSP034917A (es) Nuevos derivados de acido sulfonico
NI200400073A (es) Compuestos de fenilsulfonamida sustituida inhibidores de la produccion de beta-amiloide
GT200000190A (es) Procedimiento para la obtencion de 1,2,3,4-tetrahidroquinolinas-4-carboxiamino-2-sustituidas.
ES2180933T3 (es) Inhibidor de la serina-proteasa.
CY1107635T1 (el) Μεθοδος για την παρασκευη σιταλοπραμης
DE60300986D1 (de) Verfahren zur herstellung einer pharmazeutisch aktiven verbindung (granisetron)
BR0209901A (pt) Processos para a sìntese de derivados de 2,3-dihidro-1,4-dioxino-[2,3-f] quinolina
ES2159488B1 (es) Procedimiento para la preparacion de derivados de pirimidona con actividad antifungica.
ES2167721T3 (es) Utilizacion de 1-hidroxi-2-piridonas para el tratamiento de la dermatitis seborreica.
BRPI0013751B8 (pt) processo para produção de derivados de ácido naftiridina-3-carboxílico.
MX9307510A (es) Un procedimiento para la preparacion de derivados de ester de acido fenilacetico.
PA8525601A1 (es) Profarmacos de (3s,4s)-4-bencil-1-[2-(4-hidroxi-bencenosulfonil)-etil]-piperidin-3-ol
EP1258478A4 (en) PROCESS FOR THE PREPARATION OF CHINOLONCARBOXYLIC ACIDS AND THEIR INTERMEDIATE PRODUCTS
TR200001161A2 (tr) 8-Siklopentil-6-etil-3-[ikame edilmiş]-5, 8-Dihidro-4H-1, 2, 3A, 7, 8-Pentaaza-As-Indasenlerin hazırlandığı işlem ve burada yararlı ara bağlar.
AR029004A1 (es) Compuesto del acido 7-acilamino-3-heteroariltio-3-cefem carboxilico y su uso para la preparacion de una composicion antibacteriana
IT1313569B1 (it) Processo per la sintesi di derivati beta-lattamici.
DE60014053D1 (de) Farnesyltransferase-inhibitoren die eine pyrrolstruktur haben und verfahren zu ihrer herstellung
BR0009795A (pt) Processo para a ppeparação de um composto da fórmula (i), e, composto